- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Brian A. White
News 9 results
Recognition
March 22, 2024
King & Spalding Ranked Number One in International Arbitration For Fourth Year
In the News · Source: Law360
Recognition
March 31, 2023
King & Spalding Once Again Earns Top Spot on Global Arbitration Review’s GAR 30 Ranking
Recognition
September 16, 2022
King & Spalding Recognized for its Leadership in Atlanta-Area Deals of the Year
Events 4 results
Conference
November 7, 2023
Pharmaceutical University 2023
Speaking Engagement
December 9, 2022
Dirk Lasater to Speak at Association of Corporate Counsel National Capital Region Conference
Webinar
March 30, 2022
Maximizing Contract and Treaty-Based Protections For Cross-Border Transactions in the Pharmaceutical Industry
Conference
June 9, 2016
King & Spalding Fifth Annual Patent Law Seminar
Insights 4 results
Client Alert
March 24, 2022
Potential Remedies for Russia’s Suspension of Foreign Investors’ Intellectual Property Rights
Article · Source: Jus Mundi
September 4, 2020
Arbitration Team of The Month (September) – King & Spalding
Article
February 24, 2017
ABA Publishes Practice Reference by James Berger, “International Aspects of U.S. Litigation”
Client Alert
November 12, 2015
Establishing the Application of The Foreign Sovereign Immunities Act’s Arbitration Exception